State of the Art
Equipped with a state-of-the-art research facility, Rx Biosciences provides a robust infrastructure to manage both small- and large-scale projects. Our laboratories feature the latest scientific technologies, including a fully automated Affymetrix platform for microarray analysis, advanced sequencers from ABI, Illumina, and Beckman, a Pulse Field Gel Electrophoresis apparatus, ultracentrifuges, liquid handling platforms, as well as comprehensive cell culture and animal housing facilities.
Contract Research Services
Rx Biosciences offers a comprehensive range of custom antibody generation and modulation services. These include raising polyclonal and monoclonal antibodies using conventional methods, preparing scFv, Fab, nanobody, and IgNAR libraries in phage-display vectors, as well as antibody maturation, humanization, and assay development. In addition to phage display, we provide other display platforms such as bacterial, yeast, mRNA, and ribosomal display services.
Our expertise also extends to various cDNA and genomic library construction services, including libraries in phage display and BAC vectors. Furthermore, Rx Biosciences specializes in the production of bulk quantities of endotoxin-free, high-grade plasmid and viral DNA, ensuring the highest standards of quality for research and clinical applications.
ABOUT US
Your Partner in Gene Research
Rx Biosciences is strategically situated in the biotechnology corridor of Montgomery County, Maryland, USA, placing it in close proximity to key clients and collaborators, including the NIH, NCI, USDA, DOD, and prominent universities and research institutions.
Over the past decade, Rx Biosciences has been at the forefront of innovation, designing and developing cutting-edge modules and technologies to advance research in protein engineering and genetic recombination. Our team comprises highly skilled professionals with diverse and extensive research experience, fostering a culture of expertise and excellence.
Research and Development
Rx Biosciences is dedicated to advancing scientific knowledge and innovation. Our researchers are actively investigating the genetic mechanisms underlying the onset and progression of prostate cancer and leukemia. Notably, we are funded by the National Cancer Institute (NCI) to identify clinically significant substrates for Pim-1 kinase, with a focus on real-time substrate phosphorylation technology.
We are also developing advanced gene silencing technologies aimed at achieving more controlled and guided suppression of target genes. This cutting-edge approach is expected to surpass the efficiency of traditional siRNA-based methods.
Product Development
Rx Biosciences is committed to the development, patenting, production, and marketing of innovative products that facilitate drug discovery and targeted delivery through ligands. Our ongoing efforts are focused on providing robust solutions to meet the evolving needs of the pharmaceutical and biotechnology industries.
Publications
Explore our recently published accomplishments and projects with notable clients.
"Rx Biosciences is actively working on developing a promising technology named as ANTHILL Technology) which when coupled with nanotechnology shows great promise ant appears superior to siRNA…"
Gregory J. Riggins
Professor of Neurosurgery and Oncology"We thank Rx Biosciences for preparing a great batch of cDNA and his persistence in getting it cloned."
Sigma Chemical Company
The team at Rx Biosciences is extremely knowledgeable and assists with genomics services from simple, to more complex R&D projects. Their expertise is very valuable, and I would not hesitate to recommend them.
Areti Karadimos
Research Director, Bio S&TI contracted the construction of a metagenomic library from RxBiosciences. They provided a high quality library at a good price and with a quick turnaround time. Notably, they are able to make libraries with many more unique clones than I could find from other companies.
